Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial.
Farhad FazelHossein NikpourMohsen PouraziziPublished in: BioMed research international (2020)
This randomized contralateral clinical trial demonstrated that adjuvant topical dorzolamide with IVB injection had no additional effects on IVB in the treatment of DME over a three-month course. This trial is registered with the Iranian Registry of Clinical Trials under the registration code IRCT20131229015975N5.
Keyphrases
- clinical trial
- phase ii
- phase iii
- double blind
- open label
- vascular endothelial growth factor
- study protocol
- placebo controlled
- diabetic retinopathy
- age related macular degeneration
- metastatic colorectal cancer
- early stage
- wound healing
- randomized controlled trial
- combination therapy
- ultrasound guided
- optical coherence tomography